![Frontiers | Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration Frontiers | Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration](https://www.frontiersin.org/files/Articles/841873/fphar-13-841873-HTML/image_m/fphar-13-841873-g001.jpg)
Frontiers | Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration
![Dosing table for dose selection of betamethasone and placebo solutions | Download Scientific Diagram Dosing table for dose selection of betamethasone and placebo solutions | Download Scientific Diagram](https://www.researchgate.net/publication/348051275/figure/tbl1/AS:986108900950022@1612118091668/Dosing-table-for-dose-selection-of-betamethasone-and-placebo-solutions.png)
Dosing table for dose selection of betamethasone and placebo solutions | Download Scientific Diagram
![Development of the open‐source dose calculation and optimization toolkit matRad - Wieser - 2017 - Medical Physics - Wiley Online Library Development of the open‐source dose calculation and optimization toolkit matRad - Wieser - 2017 - Medical Physics - Wiley Online Library](https://aapm.onlinelibrary.wiley.com/cms/asset/69eafc54-2cfd-4f72-a05b-7719922ae153/mp12251-fig-0003-m.jpg)
Development of the open‐source dose calculation and optimization toolkit matRad - Wieser - 2017 - Medical Physics - Wiley Online Library
![Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults - The Lancet Infectious Diseases Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12392921-6629-40da-9c71-615eff4e373c/gr1.gif)
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults - The Lancet Infectious Diseases
![Why Moderna's FDA-authorized COVID shot for under 5s has edge over Pfizer's [Updated] | Ars Technica Why Moderna's FDA-authorized COVID shot for under 5s has edge over Pfizer's [Updated] | Ars Technica](https://cdn.arstechnica.net/wp-content/uploads/2022/06/Screen-Shot-2022-06-15-at-2.19.49-PM.jpeg)
Why Moderna's FDA-authorized COVID shot for under 5s has edge over Pfizer's [Updated] | Ars Technica
![PLA 3.0 – Software for Biostatistical Analysis: Parallel logistic potency assays (3PL, 4PL, 5PL) in PLA 3.0 PLA 3.0 – Software for Biostatistical Analysis: Parallel logistic potency assays (3PL, 4PL, 5PL) in PLA 3.0](https://www.bioassay.de/fileadmin/user_upload/nonlinear-quantitative-response-assay-2017.jpg)
PLA 3.0 – Software for Biostatistical Analysis: Parallel logistic potency assays (3PL, 4PL, 5PL) in PLA 3.0
![3M™ Soluprep™ Quarter Dose (QD) Swab (0.5% w/v chlorhexidine gluconate and 70% v/v ethyl alcohol), 102.02, non-sterile, clear, small | 3M Canada 3M™ Soluprep™ Quarter Dose (QD) Swab (0.5% w/v chlorhexidine gluconate and 70% v/v ethyl alcohol), 102.02, non-sterile, clear, small | 3M Canada](https://multimedia.3m.com/mws/media/1330733P/a-carton-of-3m-soluprep-qd-small-swab-clear-0-5-w-v-chg-70-v-v-ipa.jpg)